The current status of the rotavirus vaccine

Robert M. Jacobson

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


The US just licensed of an oral tetravalent rhesus reassortant vaccine for routine immunization of infants against rotavirus. The virus was first identified 25 years ago and is now recognized to be the most common single cause of severe diarrhea throughout the world. Most children suffer at least one infection and reinfection is common. Studies of natural immunity show that breastfeeding may merely delay onset of primary infection and that maternal immunity has little effect-especially in developing countries where onset in early infancy is common. Immunity, furthermore, appears to be serotype-specific. Early attempts to develop a vaccine focused on animal forms of rotavirus. More recent efforts have created human-animal reassortants that have been far more successful.

Original languageEnglish (US)
Pages (from-to)1690-1699
Number of pages10
Issue number13-14
StatePublished - Jan 1999


  • Diarrhea
  • Rotavirus
  • Vaccine

ASJC Scopus subject areas

  • Molecular Medicine
  • General Immunology and Microbiology
  • General Veterinary
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'The current status of the rotavirus vaccine'. Together they form a unique fingerprint.

Cite this